In this study, TM5441 prevented the pathophysiological condition of COPD, and PAI-1 inhibition may represent a promising alternative therapeutic strategy that targets an upstream driver of both inflammation and tissue destruction. Here, SERPINE1 is linked to chronic obstructive pulmonary disease.